1-2 of 2
Kerry Quinn-Senger, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Eculizumab Reduces Pulmonary Hypertension through Inhibition of Hemolysis-Associated Nitric Oxide Consumption in Patients with Paroxysmal Nocturnal Hemoglobinuria

Anita Hill, MD, Russell P. Rother, PhD, Xunde Wang, MD, Robert J Sapsford, MD, Paul O Collinson, MD, David C Gaze, PhD, Sidney M Morris, Jr., PhD, Andrew Scally, Kerry Quinn-Senger, PhD, Stephen J Richards, PhD, Monica Bessler, MD, PhD, Richard Kelly, MD, Peter Hillmen, MBChB, PhD, Mark Gladwin, MD
Journal: Blood
Blood (2008) 112 (11): 486.
https://doi.org/10.1182/blood.V112.11.486.486
Published: 2008
Journal Articles

Effect of the Terminal Complement Inhibitor Eculizumab on Patient Reported Outcomes in Paroxysmal Nocturnal Hemoglobinuria (PNH): Phase III Triumph Study Results.

Robert A. Brodsky, MD, Petra Muus, MD, PhD, Ulrich Dührsen, DM, Anita Hill, MB, MD, Monica Bessler, MD, PhD, Steven Coutre, MD, Raquel De Paz, MD, Tibor Moskovits, MD, Ryotaro Nakamura, MD, Eric Van den Neste, MD, Alberto Zanella, MD, Kerry Quinn-Senger, PhD, Henk-Andre Kroon, MD, David Cella, PhD
Journal: Blood
Blood (2006) 108 (11): 3770.
https://doi.org/10.1182/blood.V108.11.3770.3770
Published: 2006